Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -519 | -519 | -328 | -817 | -597 |
| Depreciation Amortization | 222 | 176 | 77 | 84 | 11 |
| Other Working Capital | 7 | 0 | -5 | 185 | 141 |
| Other Operating Activity | 94 | 200 | 184 | 368 | 343 |
| Operating Cash Flow | $-196 | $-143 | $-73 | $-180 | $-101 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -1 | -1 |
| Investing Cash Flow | $0 | $0 | $0 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 209 | 135 | 35 | 259 | 201 |
| Financing Cash Flow | $209 | $135 | $35 | $259 | $201 |
| Beginning Cash Position | 92 | 92 | 92 | 14 | 14 |
| End Cash Position | 105 | 84 | 54 | 92 | 112 |
| Net Cash Flow | $13 | $-8 | $-38 | $78 | $98 |
| Free Cash Flow | |||||
| Operating Cash Flow | -196 | -143 | -73 | -180 | -101 |
| Capital Expenditure | 0 | 0 | 0 | -1 | -1 |
| Free Cash Flow | -196 | -143 | -73 | -182 | -103 |